Surveying BTKi Options for CLL Treatment: Ibrutinib / Zanubrutinib / Acalabrutinib / Pirtobrutinib Efficacy Data & Combination Therapy Considerations | VuMedi

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

Remaining Time 0:00

10 seconds

Playback speed

Surveying BTKi Options for CLL Treatment: Ibrutinib / Zanubrutinib / Acalabrutinib / Pirtobrutinib Efficacy Data & Combination Therapy Considerations

By Adam Kittai 2 Videos

198 views

May 3, 2021

Comments 0

Login to view comments. Click here to Login